106 related articles for article (PubMed ID: 1678315)
1. Binding of insulin-like growth factors to Tera-2 human embryonal carcinoma cells during differentiation.
Fleck JF; Sledge GW; Benenati SV; Frolik CA; Roth BJ; Hirsch KS
Cancer Res; 1991 Aug; 51(16):4395-401. PubMed ID: 1678315
[TBL] [Abstract][Full Text] [Related]
2. Binding of insulin-like growth factors to cultured rat calvarial cells with differing biologic responses.
Cantrell PR; Frolik CA; Ellis LF; Williams DC
J Bone Miner Res; 1991 Aug; 6(8):851-7. PubMed ID: 1664647
[TBL] [Abstract][Full Text] [Related]
3. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
4. Possible autocrine/paracrine actions of insulin-like growth factors during embryonic development: expression and action of IGFs in undifferentiated P19 cells.
Eicher DJ; Moats-Staats BM; Stiles AD; D'Ercole AJ
Dev Genet; 1993; 14(3):194-203. PubMed ID: 8358865
[TBL] [Abstract][Full Text] [Related]
5. Characterization of insulin-like growth factor receptors in the insulin-responsive R3230AC mammary adenocarcinoma.
Korc-Grodzicki B; Furlanetto RW; Hilf R
Oncol Res; 1992; 4(3):109-19. PubMed ID: 1377520
[TBL] [Abstract][Full Text] [Related]
6. Autocrine function for insulin-like growth factor I in human small cell lung cancer cell lines and fresh tumor cells.
Macaulay VM; Everard MJ; Teale JD; Trott PA; Van Wyk JJ; Smith IE; Millar JL
Cancer Res; 1990 Apr; 50(8):2511-7. PubMed ID: 2156621
[TBL] [Abstract][Full Text] [Related]
7. Rabbit slow and fast skeletal muscle-derived satellite myoblast phenotypes do not involve constitutive differences in the components of the insulin-like growth factor system.
Barjot C; Navarro M; Cotten ML; Garandel V; Bernardi H; Bacou F; Barenton B
J Cell Physiol; 1996 Nov; 169(2):227-34. PubMed ID: 8908189
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
McCusker RH; Camacho-Hubner C; Bayne ML; Cascieri MA; Clemmons DR
J Cell Physiol; 1990 Aug; 144(2):244-53. PubMed ID: 2166057
[TBL] [Abstract][Full Text] [Related]
9. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.
Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM
J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654
[TBL] [Abstract][Full Text] [Related]
10. Receptor binding and mitogenic effects of insulin and insulinlike growth factors I and II for human myeloid leukemic cells.
Pepe MG; Ginzton NH; Lee PD; Hintz RL; Greenberg PL
J Cell Physiol; 1987 Nov; 133(2):219-27. PubMed ID: 2960684
[TBL] [Abstract][Full Text] [Related]
11. IGF-I, IGF-II and insulin promote differentiation of spermatogonia to primary spermatocytes in organ culture of newt testes.
Nakayama Y; Yamamoto T; Abé SI
Int J Dev Biol; 1999 Jul; 43(4):343-7. PubMed ID: 10470651
[TBL] [Abstract][Full Text] [Related]
12. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
[TBL] [Abstract][Full Text] [Related]
13. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
Minniti CP; Maggi M; Helman LJ
Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I receptors in normal and neoplastic human endometrium.
Talavera F; Reynolds RK; Roberts JA; Menon KM
Cancer Res; 1990 May; 50(10):3019-24. PubMed ID: 2159368
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor (IGF) binding to a murine mammary epithelial cell line.
Hadsell DL; Gibson CA; Baumrucker CR
J Cell Physiol; 1994 Dec; 161(3):435-40. PubMed ID: 7525614
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
Nakanishi Y; Mulshine JL; Kasprzyk PG; Natale RB; Maneckjee R; Avis I; Treston AM; Gazdar AF; Minna JD; Cuttitta F
J Clin Invest; 1988 Jul; 82(1):354-9. PubMed ID: 2839551
[TBL] [Abstract][Full Text] [Related]
17. Effects of various growth factors on growth of a cloned human esophageal squamous cancer cell line in a protein-free medium.
Oku K; Tanaka A; Yamanishi H; Nishizawa Y; Matsumoto K; Shiozaki H; Mori T
Anticancer Res; 1991; 11(4):1591-5. PubMed ID: 1746916
[TBL] [Abstract][Full Text] [Related]
18. Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain.
Kar S; Chabot JG; Quirion R
J Comp Neurol; 1993 Jul; 333(3):375-97. PubMed ID: 8349849
[TBL] [Abstract][Full Text] [Related]
19. Expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during Caco-2 cell proliferation and differentiation.
Park JH; Corkins MR; Vanderhoof JA; Caruso NM; Hrbek MJ; Schaffer BS; Slentz DH; McCusker RH; MacDonald RG
J Cell Physiol; 1996 Feb; 166(2):396-406. PubMed ID: 8592000
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor enhances production of insulin-like growth factor binding proteins in a human adenocarcinoma cell line (HEC-1A).
Giannini S; Maggi M; Cresci B; Finetti G; Bonaccorsi L; Luconi M; Rotella CM; Forti G; Serio M; Baldi E
Gynecol Oncol; 1996 Jun; 61(3):333-40. PubMed ID: 8641611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
